Standout Papers
- Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study (2005)
- Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies (2007)
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies (2009)
- Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial (2013)
Immediate Impact
22 from Science/Nature 154 standout
Citing Papers
Genetic and biological hallmarks of colorectal cancer
2021 Standout
A view on drug resistance in cancer
2019 StandoutNature
Works of Silvio Veronese being referenced
Oncogenic Activation of the RAS/RAF Signaling Pathway Impairs the Response of Metastatic Colorectal Cancers to Anti–Epidermal Growth Factor Receptor Antibody Therapies
2007 Standout
Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study
2005 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Silvio Veronese | 3546 | 1975 | 1565 | 89 | 5.3k | |
| Francesca Molinari | 3036 | 1508 | 1475 | 52 | 4.6k | |
| Milo Frattini | 4800 | 2409 | 2603 | 107 | 7.5k | |
| Gorana Tomasic | 4340 | 1383 | 1661 | 63 | 5.9k | |
| Gunter Schuch | 2719 | 1485 | 1763 | 68 | 4.9k | |
| Tamás Pintér | 4506 | 2616 | 892 | 50 | 5.7k | |
| Lowell L. Hart | 3433 | 2166 | 1702 | 125 | 5.4k | |
| Teresa Troiani | 3559 | 1952 | 2375 | 180 | 5.8k | |
| Dirk Laurent | 2896 | 1450 | 1501 | 76 | 4.5k | |
| Ferry A.L.M. Eskens | 2813 | 1446 | 2570 | 159 | 6.2k | |
| Rona Yaeger | 3831 | 1334 | 2334 | 194 | 5.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...